Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | EXP | | 6480464 | Demecolcine results in increased expression of GPATCH2 mRNA | CTD | PMID:23649840 | (S)-nicotine | increases splicing | EXP | | 6480464 | Nicotine results in increased splicing of GPATCH2 mRNA alternative form | CTD | PMID:23825647 | 17beta-estradiol | increases expression | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of GPATCH2 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of GPATCH2 mRNA | CTD | PMID:29704546 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GPATCH2 mRNA | CTD | PMID:33387578 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of GPATCH2 mRNA | CTD | PMID:30851411 | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of GPATCH2 mRNA | CTD | PMID:37199045 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Gpatch2 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of GPATCH2 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Gpatch2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of GPATCH2 gene | CTD | PMID:31683443 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of GPATCH2 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases expression | ISO | Gpatch2 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of GPATCH2 mRNA | CTD | PMID:19770486 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of GPATCH2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of GPATCH2 3' UTR | CTD | PMID:27901495 | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of GPATCH2 intron | CTD | PMID:30157460 | bisphenol A | increases expression | ISO | Gpatch2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of GPATCH2 mRNA | CTD | PMID:26063408 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of GPATCH2 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of GPATCH2 mRNA | CTD | PMID:25181051 more ... | C60 fullerene | decreases expression | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of GPATCH2 mRNA | CTD | PMID:19167457 | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of GPATCH2 protein | CTD | PMID:35688186 | clofibrate | decreases expression | ISO | Gpatch2 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of GPATCH2 mRNA | CTD | PMID:17585979 | Cuprizon | increases expression | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of GPATCH2 mRNA | CTD | PMID:26577399 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of GPATCH2 mRNA | CTD | PMID:20106945 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of GPATCH2 mRNA | CTD | PMID:29803840 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of GPATCH2 mRNA | CTD | PMID:27188386 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of GPATCH2 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPATCH2 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of GPATCH2 mRNA | CTD | PMID:23649840 | formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of GPATCH2 mRNA | CTD | PMID:23649840 | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of GPATCH2 protein | CTD | PMID:37730182 | gentamycin | increases expression | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of GPATCH2 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of GPATCH2 mRNA | CTD | PMID:20044591 | ketoconazole | increases expression | EXP | | 6480464 | Ketoconazole results in increased expression of GPATCH2 mRNA | CTD | PMID:36621641 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of GPATCH2 mRNA | CTD | PMID:28988120 | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of GPATCH2 intron | CTD | PMID:30157460 | methoxychlor | affects methylation | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of GPATCH2 gene | CTD | PMID:35440735 | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of GPATCH2 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of GPATCH2 mRNA | CTD | PMID:28001369 | N-ethyl-N-nitrosourea | increases mutagenesis | ISO | Gpatch2 (Mus musculus) | 6480464 | Ethylnitrosourea results in increased mutagenesis of GPATCH2 mRNA | CTD | PMID:27776689 | nicotine | increases splicing | EXP | | 6480464 | Nicotine results in increased splicing of GPATCH2 mRNA alternative form | CTD | PMID:23825647 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GPATCH2 mRNA | CTD | PMID:26690555 | paracetamol | increases expression | ISO | Gpatch2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of GPATCH2 mRNA | CTD | PMID:33387578 | phenylmercury acetate | affects expression | EXP | | 6480464 | Phenylmercuric Acetate affects the expression of GPATCH2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of GPATCH2 mRNA | CTD | PMID:27188386 | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of GPATCH2 mRNA | CTD | PMID:30851411 | resorcinol | decreases expression | EXP | | 6480464 | resorcinol results in decreased expression of GPATCH2 mRNA | CTD | PMID:22623647 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of GPATCH2 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of GPATCH2 mRNA | CTD | PMID:25351596 | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of GPATCH2 mRNA | CTD | PMID:31758290 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of GPATCH2 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPATCH2 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of GPATCH2 mRNA | CTD | PMID:24935251 and PMID:26272509 | triptonide | affects expression | ISO | Gpatch2 (Mus musculus) | 6480464 | triptonide affects the expression of GPATCH2 mRNA | CTD | PMID:33045310 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of GPATCH2 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | Gpatch2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of GPATCH2 mRNA | CTD | PMID:17292431 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of GPATCH2 mRNA | CTD | PMID:28001369 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of GPATCH2 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of GPATCH2 mRNA | CTD | PMID:25979313 | vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of GPATCH2 mRNA | CTD | PMID:23649840 | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of GPATCH2 mRNA | CTD | PMID:27188386 | zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of GPATCH2 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of GPATCH2 mRNA | CTD | PMID:18593933 | |